Ad
Tuesday, 13 March 2018
Roche CEO says new drugs will offset biosimilar incursions
ZURICH (Reuters) - Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from rivals' copies through its new medicines, Chief Executive Severin Schwan said on Tuesday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment